{
  "id": 7959835,
  "title": "Brainlab: „Revolutionärer Schritt“ – neues Verfahren zur Lungentumorbestrahlung entwickelt",
  "url": "https://urgent.news/2026/09/17/brainlab-revolutionarer-schritt-neues-verfahren-zur",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-17T05:32:37.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/technik/medizin/brainlab-neues-verfahren-zur-lungentumorbestrahlung-entwickelt/100253962.html"
  },
  "original_language": "de",
  "account": "Munich – The specialist in medical technology, Brainlab, aims to enhance radiotherapy for lung cancer with a novel method. CEO Rainer Birkenbach informed the Handelsblatt that \"five out of every 100 individuals will develop a lung tumor, and four of them will not survive the first five years.\" Lung cancer is often diagnosed late and challenging to treat due to the lung's movement during radiation therapy. Consequently, the tumour's moving area is often irradiated, subjecting healthy tissue to harm. To significantly reduce this effect, Brainlab introduces its \"Advanced Motion Management\" after EU certification, set to enter the market on Thursday. Birkenbach described this development as \"a revolutionary step.\" Brainlab is one of the pioneers in software-assisted surgery and tumour therapy; however, a planned stock market listing last year collapsed. Though the initial share issuance was overvalued due to a challenging capital market environment, industry circles feared inadequate demand and a price drop following the initial listing. Founders Stefan Vilsmeier had hoped for a valuation reaching up to two billion euros.",
  "summary": "Nach dem geplatzten Börsengang will der Medizintechnik-Spezialist seinen Wachstumskurs fortsetzen. Eine neue Technologie soll auch bei anderen Krebsarten zum Einsatz kommen.",
  "key_points": [
    "Brainlab develops new lung tumor radiation method",
    "CEO Rainer Birkenbach calls it revolutionary step",
    "Advanced Motion Management enters market Thursday"
  ],
  "editors_take": "Brainlab's new Advanced Motion Management method aims to significantly reduce harm to healthy tissue during lung cancer radiotherapy by addressing the lung's movement during treatment.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}